I wonder if the $20m acquisition facility will be aimed at Adherium (I hold.) With Respiri now in RPM and solely focused on the US, and if the terms were realistic, a deal could make a lot more sense to ADR shareholders than it did a few years ago.
Also, a well funded merged group would be far more likely to get traction on the ASX than either company could on its own.
I wonder if the $20m acquisition facility will be aimed at...
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.25M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 165814 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 189727 | 2 |
View Market Depth
| Last trade - 16.12pm 30/08/2024 (20 minute delay) ? |
| RSH (ASX) Chart |
Day chart unavailable